Kodal Minerals (AIM: KOD) – Flash Note – From maiden production to scaled growth at Bougouni - Share Talk

Kodal Minerals (AIM: KOD) – Flash Note – From maiden production to scaled growth at Bougouni

Kodal Minerals* (KOD LN) 0.40p, Mkt Cap £81m – Flash Note – From maiden production to scaled growth at Bougouni

BUY – 0.86p

CLICK FOR PDF

  • We update on Kodal Minerals, the only AIM listed pure play hard rock lithium producer, highlighting latest developments at the Bougouni Lithium Mine in southern Mali and expansion plans amid a strong recovery in lithium prices.
  • Bougouni Lithium Mine (32% KOD) was commissioned in early 2025 and is ramping up Stage 1 (DMS) production to ~120ktpa SC5.5 (~110ktpa SC6), making Kodal the second only lithium producer in the country.
  • Stage 2 (FLO) commissioning is targeted for late 2028 and is expected to increase output to ~240ktpa SC5.5 (~220ktpa SC6), supported by a 32Mt @ 1.06% Li2O MRE and a medium-term resource target of 50Mt.
  • Stage 2 is expected to deliver higher tonnage at lower unit costs (~220ktpa SC6 at ~$700/SC6 FOB AISC vs ~110ktpa SC6 at ~$750/SC6 FOB AISC for Stage 1) and one of the lowest capital intensities among hard-rock flotation projects (~$94/ore vs >$300/ore peer average).
  • At $1,750/SC6 CIF, we estimate ~$190M Revenue and ~ $110M EBITDA pa under Stage 1, rising to ~$375M revenue and ~$225M EBITDA pa following Stage 2 commissioning (100% interest basis).
  • ~$190M Stage 2 capex (SPAe; mid point of the guided $175-200M range) is estimated to be self-funded from Stage 1 cash flows at >$1,700/SC6 CIF, with current spot prices >$2,000 providing a meaningful funding buffer.
  • Stage 1 (DMS) is expected to deplete by mid-2029 on the current MRE, with scope to extend feed via additional DMS-amenable material, including Boumou, offering downside protection if Stage 2 is delayed.
  • Recent fiscal and security developments in Mali raises jurisdiction risk, although, Bougouni continues to operate and export without disruption.
  • Strong strategic backing from Hainan Mining (JV partner and ~15% shareholder) that fully funded the Stage 1 (DMS) with a $100M investment and holding 100% offtake from Stage 1 (Stage 2 remains uncontracted and may be used in project funding discussions if required) and continues to provide operational and financial support.
  • Leverage to lithium price recovery with base case valuation assuming $1,750/SC6 CIF, below current spot prices, offering meaningful upside to NAV and cash generation if prices remain elevated.
  • Solid balance sheet with ~£15M cash (Dec/25) and no bank debt.

Valuation: Risked NAV ~US$230M and TP 0.86p at $1,750/SC6 CIF (base case) implying ~115% potential upside and supporting a BUY recommendation. ~$290M and 1.08p at $2,000/SC6 CIF. Kodal offers compelling upside driven by Stage 1 ramp-up, self-funded Stage 2 expansion and further resource growth potential. A sustained lithium price recovery and successful delivery of the FLO expansion could support valuation upside to >1.0p and beyond, underpinning our positive view on the stock.

*SP Angel acts as financial advisor and broker to Kodal Minerals.

Analysts

Sergey Raevskiy –Sergey.Raevskiy@spangel.co.uk – 0203 470 0474

John Meyer –John.Meyer@spangel.co.uk – 0203 470 0490

Simon Beardsmore – Simon.Beardsmore@spangel.co.uk – 0203 470 0484

Arthur Parish – Arthur.Parish@spangel.co.uk – 0203 470 0476

Sales

Richard Parlons –Richard.Parlons@spangel.co.uk – 0203 470 0472

Abigail Wayne –Abigail.Wayne@spangel.co.uk – 0203 470 0534

Rob Rees –Rob.Rees@spangel.co.uk – 0203 470 0535

Grant Barker – Grant.Barker@spangel.co.uk – 0203 470 0471

Prince Frederick House

35-39 Maddox Street

London, W1S 2PP

*SP Angel are the No1 integrated nomad and broker by number of mining brokerage clients on AIM according to the AIM Advisers Ranking Guide (joint brokerships excluded)

+SP Angel employees may have previously held, or currently hold, shares in the companies mentioned in this note.

DISCLAIMER

This note is a marketing communication and comprises non-independent research. This means it has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of its dissemination.

This note is intended only for distribution to Professional Clients and Eligible Counterparties as defined under the rules of the Financial Conduct Authority and is not directed at Retail Clients.

This note is confidential and is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or published in whole or in part, for any purpose.

This note has been issued by SP Angel Corporate Finance LLP (‘SPA’) to promote its investment services. Neither the information nor the opinions expressed herein constitutes, or is to be construed as, an offer or invitation or other solicitation or recommendation to buy or sell investments. The information contained herein is based on sources which we believe to be reliable, but we do not represent that it is wholly accurate or complete. All opinions and estimates included in this report are subject to change without notice. It is not investment advice and does not take into account the investment objectives and policies, financial position or portfolio composition of any recipient. SPA is not responsible for any errors or omissions or for the results obtained from the use of such information. Where the subject of the research is a client company of SPA we may have shown a draft of the research (or parts of it) to the company prior to publication to check factual accuracy, soundness of assumptions etc.

Distribution of this note does not imply distribution of future notes covering the same issuers, companies or subject matter.

Where the investment is traded on AIM it should be noted that liquidity may be lower and price movements more volatile.

SPA, its partners, officers and/or employees may own or have positions in any investment(s) mentioned herein or related thereto and may, from time to time add to, or dispose of, any such investment(s).

SPA is registered in England and Wales with company number OC317049.  The registered office address is Prince Frederick House, 35-39 Maddox Street, London W1S 2PP.  SPA is authorised and regulated by the UK Financial Conduct Authority and is a Member of the London Stock Exchange plc.

MiFID II – Based on our analysis we have concluded that this note may be received free of charge by any person subject to the new MiFID II rules on research unbundling pursuant to the exemptions within Article 12(3) of the MiFID II Delegated Directive and FCA COBS Rule 2.3A.19.

A full analysis is available on our website here http://www.spangel.co.uk/legal-and-regulatory-notices.html. If you have any queries, feel free to contact our Compliance Officer, Tim Jenkins (tim.jenkins@spangel.co.uk).

SPA research ratings – Based on a time horizon of 12 months: Buy = Expected return of more than 15%, Hold = Expected return between -15% and +15%, Sell = Expected return

SP Angel Corporate Finance LLP is authorised and regulated by the Financial Conduct Authority and is a Member of the London Stock Exchange


Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned